88 Energy raises $17 million to strengthen balance sheet and fund upcoming drilling program

|

Published 06-MAR-2017 14:29 P.M.

|

4 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

88 Energy (ASX | AIM : 88E) announced on Monday morning that it had successfully completed a bookbuild to domestic and international institutional and sophisticated investors, raising A$17 million in an oversubscribed placement.

Not only will the capital raised fully fund upcoming drilling at the company’s Icewine#2 well project located in Alaska which should spud in the second quarter of 2017, but it will also strengthen the company’s balance sheet, providing it with options to pursue promising leads while covering potential contingencies that can occur in the course of exploration campaigns.

While the raising was done at a discount (A$0.037 per share) to the last closing price of A$0.042, the fact that it has considerably derisked progress with the highly prospective Icewine#2 project is likely to provide positive momentum once normal trading resumes.

Notably, the company’s shares traded as high as A$0.04 on Monday morning, an 8% premium to the raising price.

It should be noted that share trading patterns should not be used as the basis for an investment as they may or may not be replicated. Those considering this stock should seek independent financial advice.

Potential share price upside if 88E milestones continue

In particular, the raising gives the company the opportunity to capture the full positive share price impact of promising exploration news without the potential offset of questions that could otherwise be raised regarding near to medium-term funding.

In discussing the capital raising, Managing Director Dave Wall said, “As we approach this part of Icewine#2, it is imperative that the company’s balance sheet is managed appropriately to account for worst-case scenarios, such as cost overruns on drilling”.

To date, 88E has impressed with its ability to consistently meet milestones as outlined below.

Should everything go to plan, Wall highlighted the fact that the additional capital would be used to further the exploration effort at Project Icewine as the group looks to unlock the large potential of both the unconventional and conventional plays on the acreage.

Hartleys likes the story – three P’s important in targeting HRZ shale

Following the capital raising, analysts at Hartleys reaffirmed their positive opinion on the stock. The broker had previously modelled a breakeven oil price of US$40 per barrel in relation to a prospective production scenario.

This would provide substantial margins based on the current oil price which is in the vicinity of US$55 per barrel.

Of course, investors should be aware that like all commodities, the oil price can move up or down. Investors should not invest solely on future oil price scenarios that may or may not eventuate. Like all oil explorers, 88E is a speculative investment.

Hartleys’ confidence regarding a HRZ sweet spot is based on important facets such as thermal maturity and resource concentration, but also porosity, permeability and pressure.

The gross mean prospective recoverable resource based on 271,000 acres is estimated to be in a range between 1 billion and 2.6 billion barrels of liquids as highlighted in the following Prospective Resource Assessment:

As indicated below, the establishment of a HRZ unconventional project would be a game changer for 88E given the substantial increase in output that is traditionally achieved when transitioning from vertical to horizontal development.

88E’s growing position in highly prospective Alaskan region

Should 88E have success at Icewine#2, the resource is ideally situated in terms of infrastructure with all-year road access and the potential to tie into an existing pipeline.

88E has been expanding its position in Alaska since 2015 with its initial interest in Project Icewine occurring after the company entered into a binding agreement to acquire a significant working interest (87.5%, reducing to 77.5% on spud of the first well) in a large acreage position on a liquids-rich exploration opportunity in an onshore region of Alaska, North America.

In June 2016 the gross acreage position was expanded to 271,119 contiguous acres (net 210,000 acres to 88E). In December 2016, the company successfully bid on additional acres. On award, the project Icewine gross acreage position will be further expanded to circa 690,000 contiguous acres (approximately 400,000 acres net to 88E, assuming all rights are taken up).

For a more in-depth look at 88E, Wall gave this company presentation to investors in London last month:

tags

OIL


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X